Identification of 4-[1-[3-chloro-4-[N’-(5-fluoro-2-methylphenyl)ureido]phenylacetyl]-(4S)-fluoro-(2S)-pyrrolidinylmethoxy]benzoic acid as a potent, orally active VLA-4 antagonist

Add time:07/25/2019    Source:sciencedirect.com

Optimization of benzoic acid derivatives by introducing substituents into the diphenyl urea moiety led to the identification of compound 20l as a potent VLA-4 antagonist. Compound 20l inhibited eosinophil infiltration into bronchial alveolar lavage fluid in a murine asthma model by oral dosing and its efficacy was comparable to anti-mouse α4 antibody (R1-2). Furthermore, this compound significantly blocked bronchial hyper-responsiveness in the model.

We also recommend Trading Suppliers and Manufacturers of 2,3-Dichlorophenylacetic acid (cas 10236-60-9). Pls Click Website Link as below: cas 10236-60-9 suppliers

Prev:Fluroxypyr—a potential surrogate of 2,4-dichlorophenoxyacetic acid for retarding calyx senescence in postharvest citrus fruit
Next:Electrosynthesis of 2-benzhydrylidene-4,4-diphenyl-[1,3]oxathiolan-5-one: The reaction pathway.)